Geographic disparities in chronic obstructive pulmonary disease (COPD) hospitalization among Medicare beneficiaries in the United States

被引:51
|
作者
Holt, James B. [1 ]
Zhang, Xingyou [1 ]
Presley-Cantrell, Letitia [1 ]
Croft, Janet B. [1 ]
机构
[1] US Ctr Dis Control & Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA USA
关键词
COPD prevention; environmental risk factors; public health; population; CHRONIC-BRONCHITIS; NATIONAL-HEALTH; AIR-POLLUTION; PREVALENCE; EPIDEMIOLOGY; ASSOCIATION; POPULATION; OCCUPATION; MORTALITY; INDUSTRY;
D O I
10.2147/COPD.S19945
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: Hospitalizations for persons with chronic obstructive pulmonary disease (COPD) result in significant health care resource use and excess expenditures. Despite well-documented sociodemographic disparities in COPD outcomes, no study has characterized geographic variations in COPD hospitalization across the US. Methods: Almost 3.8 million COPD hospitalization records were extracted from Medicare claims for 1995-2006, and the total population of eligible Medicare beneficiaries was extracted from the Medicare enrollment records to calculate COPD hospitalization rates by Health Service Area (HSA), (n = 949). Spatial cluster analysis and Bayesian hierarchical spatial modeling were used to characterize the geography of COPD hospitalizations. Results: The overall COPD hospitalization rate was 11.30 per 1,000 beneficiaries for the aggregated period 1995-2006. HSA-level COPD hospitalization rates had a median of 11.7 and a range of 3.0 (Cache, UT) to 76.3 (Pike, KY). Excessive hospitalization risk was concentrated in Appalachia, the southern Great Lakes, the Mississippi Delta, the Deep South, and west Texas. In the Bayesian spatial mixture model, 73% of variability of COPD hospitalization relative risk was attributed to unidentified regional social and physical environments shared by HSAs rather than to unique local HSA factors (27%). Conclusion: We discovered distinct geographic patterns in COPD hospitalization rates and risks attributed to both regionally-shared environmental risk factors and HSA-unique environmental contexts. The correlates of these geographic patterns remain to be determined. Geographic comparisons of COPD hospitalization risk provide insights for better public health practice, policies, and programs for COPD prevention.
引用
收藏
页码:321 / 328
页数:8
相关论文
共 50 条
  • [31] Pulmonary Rehabilitation and Readmission Rates for Medicare Beneficiaries with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
    Myers, L.
    Faridi, M. K.
    Camargo, C. A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [32] Pulmonary Rehabilitation and Readmission Rates for Medicare Beneficiaries with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
    Myers, Laura C.
    Faridi, Mohammad Kamal
    Hasegawa, Kohei
    Camargo, Carlos A., Jr.
    CHRONIC OBSTRUCTIVE PULMONARY DISEASES-JOURNAL OF THE COPD FOUNDATION, 2021, 8 (04): : 427 - 440
  • [33] Incremental mortality associated with nontuberculous mycobacterial lung disease among US Medicare beneficiaries with chronic obstructive pulmonary disease
    Wang, Ping
    Marras, Theodore K.
    Hassan, Mariam
    Chatterjee, Anjan
    BMC INFECTIOUS DISEASES, 2023, 23 (01)
  • [34] Racial Disparities in Diabetes Hospitalization of Rural Medicare Beneficiaries in 8 Southeastern States
    Wan, Thomas T. H.
    Lin, Yi-Ling
    Ortiz, Judith
    HEALTH SERVICES RESEARCH AND MANAGERIAL EPIDEMIOLOGY, 2016, 3
  • [35] Hospitalization Risk for Medicare Beneficiaries With Nontuberculous Mycobacterial Pulmonary Disease
    Prevots, D. Rebecca
    Marras, Theodore K.
    Wang, Ping
    Mange, Kevin C.
    Flume, Patrick A.
    CHEST, 2021, 160 (06) : 2042 - 2050
  • [36] Respiratory events associated with concomitant opioid and sedative use among Medicare beneficiaries with chronic obstructive pulmonary disease
    Le, Tham Thi
    Park, Siyeon
    Choi, Michelle
    Wijesinha, Marniker
    Khokhar, Bilal
    Simoni-Wastila, Linda
    BMJ OPEN RESPIRATORY RESEARCH, 2020, 7 (01)
  • [37] The association between comprehensive medication review and medication adherence among medicare beneficiaries with chronic obstructive pulmonary disease
    Zhang, Xiangjun
    Sim, Yongbo
    Tsang, Chi Chun Steve
    Wang, Junling
    Finch, Christopher K.
    EXPLORATORY RESEARCH IN CLINICAL AND SOCIAL PHARMACY, 2024, 15
  • [38] GEOGRAPHIC VARIATION OF HIGH-RISK MEDICATION USE AMONG MEDICARE BENEFICIARIES IN THE UNITED STATES
    Chinthammit, C.
    Bhattacharjee, S.
    Slack, M.
    Bentley, J. P.
    Warholak, T.
    Lo-Ciganic, W.
    VALUE IN HEALTH, 2018, 21 : S45 - S46
  • [39] Factors Associated with Entering the Prescription Drug Coverage Gap Among Medicare Beneficiaries with Chronic Obstructive Pulmonary Disease
    Xu, Qingqing
    Laxa, Sarah S.
    Serna, Omar
    Sansgiry, Sujit S.
    POPULATION HEALTH MANAGEMENT, 2021, 24 (02) : 241 - 248
  • [40] Trends in Hospitalization with Chronic Obstructive Pulmonary Disease-United States, 1990-2005
    Brown, David W.
    Croft, Janet B.
    Greenlund, Kurt J.
    Giles, Wayne H.
    COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2010, 7 (01) : 59 - 62